Dr. Aldred is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
610 S Sherman St
Ste 201
Spokane, WA 99202Phone+1 509-473-0885Fax+1 509-795-0895- Is this information wrong?
Education & Training
- Oregon Health & Science University (OHSU Health)Fellowship, Vascular Neurology, 2007 - 2009
- Oregon Health & Science University (OHSU Health)Chief Residency, Neurology, 2006 - 2007
- Oregon Health & Science University (OHSU Health)Residency, Neurology, 2003 - 2007
- University of Tennessee Health Science Center College of MedicineClass of 2003
- University of TennesseeBA, Latin, Greek, Biochemistry, 1999
Certifications & Licensure
- OR State Medical License 2006 - Present
- WA State Medical License 2014 - 2026
- ID State Medical License 2019 - 2025
- AZ State Medical License 2023 - 2025
- MT State Medical License 2015 - 2025
- WI State Medical License 2009 - 2023
- IA State Medical License 2010 - 2017
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- AAN Resident Scholarship to Annual Meeting 2007
- Dr. John H. and Marjorie Burkhart Medical Education Scholarship 2002
- Join now to see all
Clinical Trials
- High and Low Dose Treatment of Carbidopa in Parkinson's Disease Start of enrollment: 2008 Aug 01
- Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes Start of enrollment: 2014 Mar 01
- Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease Start of enrollment: 2015 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsSafety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, p...Michael J Soileau, Jason Aldred, Kumar Budur, Nahome Fisseha, Victor Sc Fung
The Lancet. Neurology. 2022-12-01 - 139 citationsNational randomized controlled trial of virtual house calls for Parkinson disease.Christopher A. Beck, Denise B. Beran, Kevin M. Biglan, Cynthia M. Boyd, E. Ray Dorsey
Neurology. 2017-09-12 - 117 citationsThe past, present, and future of telemedicine for Parkinson's disease.Meredith A. Achey, Jason Aldred, Noha Aljehani, Bastiaan R. Bloem, Kevin M. Biglan
Movement Disorders. 2014-06-01
Journal Articles
- The past, present, and future of telemedicine for Parkinson's diseaseAchey, M, Aldred, JL et al., Movement Disoders, 6/29/2014
- Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's diseaseAldred JL, Brod LS, Nutt JG, Movement Disorders, 5/2012
Books/Book Chapters
Abstracts/Posters
- Levodopa-Carbidopa Intestinal Gel for the Treatment of Motor Fluctuations and Dyskinesia in Patients with Advanced Parkinson's Disease in a Real World Setting: Results...Standaert, D, Aldred, J et. al, XXIV World Congress of Neurology, Dubai, UAE, 7/2019
- Open Label Study of Pimavanserin in Patients with Comorbid Parkinson's Disease and Depression.Guskey, M, Aldred, J et al., Neuroscience Education Institute Congress, Colorado Springs, CO, USA, 2019
- Medication Use and In-Hospital Complications for Patients with Parkinson’s disease: A Retrospective Review. (Poster Presentation)Kerndt, T, Aldred J, et al., World Parkinson Congress, Montreal, Canada, 1/1/2013
- Join now to see all
Lectures
- DBS UpdateLa Crosse, WI - 1/1/2013
- Advances in Parkinson’s Care and TreatmentWisconsin Dells, WI - 1/1/2013
- Second Annual Parkinson’s SymposiumLa Crosse, WI - 1/1/2012
- Join now to see all
Press Mentions
- AbbVie Announces ABBV-951 (Foslevodopa/Foscarbidopa) Showed Improvement in Controlling Motor Fluctuations Compared to Oral Levodopa/Carbidopa Medication in Pivotal Phase 3 Trial in Patients with Advanced Parkinson's DiseaseOctober 28th, 2021
- INW Research Grows Alongside Neurology ClinicFebruary 27th, 2020
- Spokane-Based Inland Northwestern Research Offers Parkinson’s Disease Clinical Trials in SpokaneJuly 28th, 2019
- Join now to see all
Committees
- Member, MDS Telemedicine Committee 2013 - Present
- Member, Parkinson's Disease Practice Guidelines Committee
Professional Memberships
- Member
- Movement Disorders SocietyMember
- Parkinson Study GroupMember
- Dystonia Study GroupMember
- Member
Hospital Affiliations
- Providence Sacred Heart Medical Center & Children's HospitalSpokane, Washington
External Links
- Northwest Neurologicalhttp://nwn4me.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: